Given the well-described properties of HSP70 in anti-inflammation, an HSP70 activator BGP-15 exhibits a positive effect on metabolic disorders, including diabetes and obesity-induced insulin resistance [105,106,107]. Here, HSPA1A is linked to metabolic disease.